High Growth Tech Stocks To Watch In October 2024

Simply Wall St.
11 Oct 2024

The United States market has shown robust performance with a 1.2% increase over the last week and a remarkable 32% rise in the past year, while earnings are projected to grow by 16% annually. In this thriving environment, identifying high growth tech stocks involves looking for companies that not only capitalize on current technological trends but also demonstrate strong potential for sustained earnings growth.

Top 10 High Growth Tech Companies In The United States

Name Revenue Growth Earnings Growth Growth Rating
Super Micro Computer 20.86% 27.98% ★★★★★★
Sarepta Therapeutics 23.67% 44.28% ★★★★★★
TG Therapeutics 28.39% 43.54% ★★★★★★
Ardelyx 27.19% 66.44% ★★★★★★
Invivyd 42.91% 70.39% ★★★★★★
Amicus Therapeutics 20.32% 62.45% ★★★★★★
AsiaFIN Holdings 60.53% 81.55% ★★★★★★
Seagen 22.57% 71.80% ★★★★★★
Travere Therapeutics 27.16% 69.88% ★★★★★★
ImmunoGen 26.00% 45.85% ★★★★★★

Click here to see the full list of 253 stocks from our US High Growth Tech and AI Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Cinemark Holdings

Simply Wall St Growth Rating: ★★★★★☆

Overview: Cinemark Holdings, Inc., along with its subsidiaries, operates in the motion picture exhibition industry and has a market capitalization of approximately $3.28 billion.

Operations: Cinemark Holdings generates revenue primarily from its U.S. operations, contributing $2.24 billion, while its international segment adds $596.80 million.

Cinemark Holdings, transitioning into profitability this year, shows a promising trajectory with an expected earnings growth of 28.1% annually, outpacing the U.S. market average of 15.9%. Despite a challenging comparison to the broader Entertainment industry's growth rate of 3.8%, Cinemark's strategic focus on enhancing customer experience and expanding its digital engagement platforms could bolster future revenue streams, which are projected to grow at 8.9% per year—slightly above the market forecast of 8.8%. Moreover, with a robust forecast Return on Equity of 41.6% in three years' time and positive free cash flow, Cinemark is positioning itself as a resilient contender in the evolving entertainment landscape despite recent dips in quarterly earnings and revenue figures reported in September and August conferences.

  • Click here to discover the nuances of Cinemark Holdings with our detailed analytical health report.
  • Assess Cinemark Holdings' past performance with our detailed historical performance reports.

NYSE:CNK Revenue and Expenses Breakdown as at Oct 2024

Evolent Health

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Evolent Health, Inc., through its subsidiary Evolent Health LLC, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States with a market capitalization of approximately $3.01 billion.

Operations: Evolent Health, Inc. focuses on specialty care management in the U.S., generating revenue primarily from its Pharmacy Services segment, which contributes approximately $2.35 billion.

Evolent Health, amid a dynamic healthcare tech landscape, is navigating its growth trajectory with significant R&D investments and strategic mergers and acquisitions. With a 13.6% expected annual revenue increase outpacing the US market's 8.8%, and an ambitious leap toward profitability within three years, Evolent is reinforcing its market position. Recent earnings reflect this upward trend with a shift from a substantial net loss to posting modest profits, evidencing effective operational adjustments and potential resilience in its business model. Moreover, ongoing discussions for potential sales to private equity underscore investor confidence in its innovative approach to healthcare solutions.

  • Unlock comprehensive insights into our analysis of Evolent Health stock in this health report.
  • Explore historical data to track Evolent Health's performance over time in our Past section.

NYSE:EVH Revenue and Expenses Breakdown as at Oct 2024

Pure Storage

Simply Wall St Growth Rating: ★★★★★☆

Overview: Pure Storage, Inc. provides data storage and management technologies, products, and services globally with a market capitalization of approximately $17.42 billion.

Operations: Pure Storage generates revenue primarily from its computer storage devices segment, totaling approximately $3.01 billion. The company operates in the data storage and management sector, offering technologies and services across various regions.

Pure Storage is capturing attention with its robust R&D investment strategy, allocating significant resources to innovation which is evident from its R&D expenses. This emphasis on development is crucial as it supports the company's 11.3% expected annual revenue growth, outpacing the broader US market average of 8.8%. Moreover, Pure Storage's earnings are projected to surge by 37.3% annually, showcasing a strong trajectory in profitability that aligns with technological advancements and market demands. Recent strategic alliances, like the one with Commvault aimed at enhancing cyber resilience under stringent EU regulations, underscore Pure Storage’s proactive approach in adapting to evolving tech landscapes and regulatory frameworks.

  • Get an in-depth perspective on Pure Storage's performance by reading our health report here.
  • Learn about Pure Storage's historical performance.

NYSE:PSTG Earnings and Revenue Growth as at Oct 2024

Key Takeaways

  • Click here to access our complete index of 253 US High Growth Tech and AI Stocks.
  • Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
  • Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Interested In Other Possibilities?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NYSE:CNK NYSE:EVH and NYSE:PSTG.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10